Similarly, high-grade papillary or eosinophilic tumors with bizarre nuclei should be evaluated for FH loss and 2-succinyl-cysteine (2SC) accumulation to diagnose FH-deficient RCC, a hereditary leiomyomatosis-associated variant [77]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.